{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T22:28:14Z","timestamp":1767220094570,"version":"3.40.3"},"publisher-location":"Cham","reference-count":161,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030614942"},{"type":"electronic","value":"9783030614959"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/112_2020_26","type":"book-chapter","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T14:02:51Z","timestamp":1595253771000},"page":"25-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia"],"prefix":"10.1007","author":[{"given":"Afsane","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Liberale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"12","key":"26_CR1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20022156","volume":"197","author":"P Ancuta","year":"2003","unstructured":"Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, Luscinskas FW et al (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197(12):1701\u20131707","journal-title":"J Exp Med"},{"issue":"20","key":"26_CR2","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1016\/j.febslet.2005.06.087","volume":"579","author":"M Artieda","year":"2005","unstructured":"Artieda M, Cenarro A, Junquera C, Lasierra P, Mart\u00ednez-Lorenzo MJ, Pocov\u00ed M et al (2005) Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett 579(20):4503\u20134512","journal-title":"FEBS Lett"},{"issue":"1","key":"26_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2004.11.027","volume":"184","author":"MRAC Barros","year":"2006","unstructured":"Barros MRAC, Bertolami MC, Abdalla DSP, Ferreira WP (2006) Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis 184(1):103\u2013107","journal-title":"Atherosclerosis"},{"issue":"7","key":"26_CR4","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","volume":"168","author":"K-U Belge","year":"2002","unstructured":"Belge K-U, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B et al (2002) The proinflammatory CD14+ CD16+ DR++ monocytes are a major source of TNF. J Immunol 168(7):3536\u20133542","journal-title":"J Immunol"},{"issue":"11","key":"26_CR5","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","volume":"97","author":"M Benn","year":"2012","unstructured":"Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metabol 97(11):3956\u20133964","journal-title":"J Clin Endocrinol Metabol"},{"issue":"4","key":"26_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12471-017-0959-2","volume":"25","author":"SC Bergheanu","year":"2017","unstructured":"Bergheanu SC, Bodde MC, Jukema JW (2017) Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment. Neth Heart J 25(4):231\u2013242","journal-title":"Neth Heart J"},{"issue":"20","key":"26_CR7","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehx002","volume":"38","author":"SJ Bernelot Moens","year":"2017","unstructured":"Bernelot Moens SJ, Neele AE, Kroon J, van der Valk FM, Van den Bossche J, Hoeksema MA et al (2017) PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia. Eur Heart J 38(20):1584\u20131593","journal-title":"Eur Heart J"},{"issue":"S1","key":"26_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2362.1994.tb02423.x","volume":"24","author":"D Betteridge","year":"1994","unstructured":"Betteridge D, Cooper M, Saggerson E, Prichard B, Tan K, Ling E et al (1994) Platelet function in patients with hypercholesterolaemia. Eur J Clin Investig 24(S1):30\u201333","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"26_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2003.11.002","volume":"30","author":"M Blaha","year":"2004","unstructured":"Blaha M, Pecka M, Urbankova J, Blaha V, Maly J, Zadak Z et al (2004) Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholesterolaemia. Transfus Apher Sci 30(2):83\u201387","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"26_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","volume":"170","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191\u2013203","journal-title":"Atherosclerosis"},{"issue":"52","key":"26_CR11","doi-asserted-by":"crossref","first-page":"31151","DOI":"10.1074\/jbc.270.52.31151","volume":"270","author":"C Blencowe","year":"1995","unstructured":"Blencowe C, Hermetter A, Kostner GM, Deigner HP (1995) Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein. J Biol Chem 270(52):31151\u201331157","journal-title":"J Biol Chem"},{"issue":"1","key":"26_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1160\/TH17-09-0630","volume":"118","author":"A Bonaventura","year":"2018","unstructured":"Bonaventura A, Liberale L, Carbone F, Vecchie A, Diaz-Canestro C, Camici GG et al (2018) The pathophysiological role of neutrophil extracellular traps in inflammatory diseases. Thromb Haemost 118(1):6\u201327","journal-title":"Thromb Haemost"},{"issue":"2","key":"26_CR13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0021-9150(99)00406-2","volume":"150","author":"MJ Caslake","year":"2000","unstructured":"Caslake MJ, Packard CJ, Suckling KE, Holmes SD, Chamberlain P, Macphee CH (2000) Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. Atherosclerosis 150(2):413\u2013419","journal-title":"Atherosclerosis"},{"issue":"11","key":"26_CR14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL et al (2011) Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 32(11):1345\u20131361","journal-title":"Eur Heart J"},{"issue":"2","key":"26_CR15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.atherosclerosis.2008.09.025","volume":"204","author":"M Charakida","year":"2009","unstructured":"Charakida M, Tousoulis D, Skoumas I, Pitsavos C, Vasiliadou C, Stefanadi E et al (2009) Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Atherosclerosis 204(2):532\u2013537","journal-title":"Atherosclerosis"},{"issue":"3","key":"26_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2362.2007.01772.x","volume":"37","author":"H Cheng","year":"2007","unstructured":"Cheng H, Ye Z, Chiou K, Lin S, Charng M (2007a) Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden. Eur J Clin Investig 37(3):197\u2013206","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"26_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2362.2007.01772.x","volume":"37","author":"HM Cheng","year":"2007","unstructured":"Cheng HM, Ye ZX, Chiou KR, Lin SJ, Charng MJ (2007b) Vascular stiffness in familial hypercholesterolaemia is associated with C-reactive protein and cholesterol burden. Eur J Clin Investig 37(3):197\u2013206","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"26_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","volume":"173","author":"F Civeira","year":"2004","unstructured":"Civeira F (2004) Hypercholesterolemia IPoMoF. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173(1):55\u201368","journal-title":"Atherosclerosis"},{"issue":"9725","key":"26_CR19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","volume":"375","author":"Collaboration L-PS","year":"2010","unstructured":"Collaboration L-PS (2010) Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 375(9725):1536\u20131544","journal-title":"Lancet"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"205873841982715","DOI":"10.1177\/2058738419827154","volume":"33","author":"A De Stefano","year":"2019","unstructured":"De Stefano A, Mannucci L, Tamburi F, Cardillo C, Schinzari F, Rovella V et al (2019) Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases. Int J Immunopathol Pharmacol 33:2058738419827154","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"26_CR21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytokine Res 29(6):313\u2013326","journal-title":"J Interf Cytokine Res"},{"issue":"1","key":"26_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physrev.00045.2017","volume":"99","author":"C Dostert","year":"2018","unstructured":"Dostert C, Grusdat M, Letellier E, Brenner D (2018) The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiol Rev 99(1):115\u2013160","journal-title":"Physiol Rev"},{"issue":"10","key":"26_CR23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jcmg.2013.03.009","volume":"6","author":"R Duivenvoorden","year":"2013","unstructured":"Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V et al (2013) Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET\/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging 6(10):1087\u20131094","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1\u20132","key":"26_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2005.09.027","volume":"366","author":"M El Messal","year":"2006","unstructured":"El Messal M, Beaudeux J-L, Drissi A, Giral P, Chater R, Bruckert E et al (2006) Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clin Chim Acta 366(1\u20132):185\u2013189","journal-title":"Clin Chim Acta"},{"issue":"5","key":"26_CR25","first-page":"267","volume":"11","author":"S Enayati","year":"2015","unstructured":"Enayati S, Seifirad S, Amiri P, Abolhalaj M, Mohammad-Amoli M (2015) Interleukin-1 beta, interferon-gamma, and tumor necrosis factor-alpha gene expression in peripheral blood mononuclear cells of patients with coronary artery disease. ARYA Atherosclerosis 11(5):267","journal-title":"ARYA Atherosclerosis"},{"issue":"3","key":"26_CR26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.92.3.290","volume":"92","author":"J Ferrieres","year":"1995","unstructured":"Ferrieres J, Lambert J, Lussier-Cacan S, Davignon J (1995) Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 92(3):290\u2013295","journal-title":"Circulation"},{"issue":"12","key":"26_CR27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1042\/CS20170009","volume":"131","author":"CN Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a CN, Izar MC, Hort\u00eancio MN, do Amaral JB, Ferreira CE, Tuleta ID et al (2017) Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. Clin Sci 131(12):1215\u20131224","journal-title":"Clin Sci"},{"issue":"11","key":"26_CR28","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","volume":"27","author":"E Galkina","year":"2007","unstructured":"Galkina E, Ley K (2007) Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27(11):2292\u20132301","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.plipres.2017.05.001","volume":"67","author":"S Ganjali","year":"2017","unstructured":"Ganjali S, Momtazi AA, Banach M, Kovanen PT, Stein EA, Sahebkar A (2017) HDL abnormalities in familial hypercholesterolemia: focus on biological functions. Prog Lipid Res 67:16\u201326","journal-title":"Prog Lipid Res"},{"issue":"1","key":"26_CR30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2017.09.014","volume":"23","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, Momtazi-Borojeni AA, Banach M, Kovanen PT, Gotto AM Jr, Sahebkar A (2018) HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions. Drug Discov Today 23(1):171\u2013180","journal-title":"Drug Discov Today"},{"issue":"2","key":"26_CR31","first-page":"89","volume":"3","author":"S Gao","year":"2017","unstructured":"Gao S, Liu J (2017) Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Dis Trans Med 3(2):89\u201394","journal-title":"Chronic Dis Trans Med"},{"issue":"1","key":"26_CR32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2015.05.006","volume":"241","author":"PK Garg","year":"2015","unstructured":"Garg PK, McClelland RL, Jenny NS, Criqui MH, Greenland P, Rosenson RS et al (2015) Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: the multi ethnic study of atherosclerosis. Atherosclerosis 241(1):176\u2013182","journal-title":"Atherosclerosis"},{"issue":"4","key":"26_CR33","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/ATVBAHA.115.306647","volume":"36","author":"PK Garg","year":"2016","unstructured":"Garg PK, Arnold AM, Hinckley Stukovsky KD, Koro C, Jenny NS, Mukamal KJ et al (2016) Lipoprotein-associated phospholipase A2 and incident peripheral arterial disease in older adults: the cardiovascular health study. Arterioscler Thromb Vasc Biol 36(4):750\u2013756","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"26_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2004.04.006","volume":"175","author":"AM Georgieva","year":"2004","unstructured":"Georgieva AM, Ten Cate H, Keulen ET, van Oerle R, Govers-Riemslag JW, Hamuly\u00e1k K et al (2004) Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome. Atherosclerosis 175(2):345\u2013351","journal-title":"Atherosclerosis"},{"issue":"17","key":"26_CR35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","volume":"62","author":"A Ghattas","year":"2013","unstructured":"Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E (2013) Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 62(17):1541\u20131551","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"26_CR36","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","volume":"132","author":"SS Gidding","year":"2015","unstructured":"Gidding SS, Ann Champagne M, de Ferranti SD, Defesche J, Ito MK, Knowles JW et al (2015) The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation 132(22):2167\u20132192","journal-title":"Circulation"},{"issue":"Suppl_1","key":"26_CR37","volume":"134","author":"MC Gissler","year":"2016","unstructured":"Gissler MC, Willecke F, Anto Michel N, H\u00e4rtner C, Hilgendorf I, Wolf D et al (2016) The role of CD40 in endothelial and smooth muscle cells in atherosclerosis. Circulation 134(Suppl_1):A18410-A","journal-title":"Circulation"},{"issue":"5","key":"26_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2143\/AC.64.5.2042689","volume":"64","author":"D Gokalp","year":"2009","unstructured":"Gokalp D, Tuzcu A, Bahceci M, Arikan S, Pirinccioglu AG, Bahceci S (2009) Levels of proinflammatory cytokines and hs-CRP in patients with homozygous familial hypercholesterolaemia. Acta Cardiol 64(5):603\u2013609","journal-title":"Acta Cardiol"},{"issue":"4","key":"26_CR39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","volume":"29","author":"JL Goldstein","year":"2009","unstructured":"Goldstein JL, Brown MS (2009) The LDL receptor. Arterioscler Thromb Vasc Biol 29(4):431\u2013438","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1\u20132","key":"26_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2009.06.029","volume":"408","author":"B Goswami","year":"2009","unstructured":"Goswami B, Rajappa M, Mallika V, Shukla DK, Kumar S (2009) TNF-alpha\/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone north Indian patients with acute myocardial infarction. Clin Chim Acta 408(1\u20132):14\u201318","journal-title":"Clin Chim Acta"},{"issue":"2","key":"26_CR41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2009.06.006","volume":"207","author":"O Guardamagna","year":"2009","unstructured":"Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M (2009) Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 207(2):471\u2013475","journal-title":"Atherosclerosis"},{"issue":"3","key":"26_CR42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2003.01767.x","volume":"59","author":"M Gurnell","year":"2003","unstructured":"Gurnell M (2003) PPAR\u03b3 and metabolism: insights from the study of human genetic variants. Clin Endocrinol 59(3):267\u2013277","journal-title":"Clin Endocrinol"},{"issue":"4","key":"26_CR43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s004280000239","volume":"437","author":"T H\u00e4kkinen","year":"2000","unstructured":"H\u00e4kkinen T, Karkola K, Yl\u00e4-Herttuala S (2000) Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Virchows Arch 437(4):396\u2013405","journal-title":"Virchows Arch"},{"issue":"3","key":"26_CR44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH14-06-0509","volume":"113","author":"X Han","year":"2015","unstructured":"Han X, Boisvert WA (2015) Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 113(3):505\u2013512","journal-title":"Thromb Haemost"},{"issue":"12","key":"26_CR45","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","volume":"21","author":"GK Hansson","year":"2001","unstructured":"Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21(12):1876\u20131890","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"26_CR46","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695","journal-title":"N Engl J Med"},{"issue":"7","key":"26_CR47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"26_CR48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/joim.12406","volume":"278","author":"GK Hansson","year":"2015","unstructured":"Hansson GK, Libby P, Tabas I (2015) Inflammation and plaque vulnerability. J Intern Med 278(5):483\u2013493","journal-title":"J Intern Med"},{"issue":"10","key":"26_CR49","first-page":"645","volume":"56","author":"A Heidari-Bakavoli","year":"2018","unstructured":"Heidari-Bakavoli A, Hassanian SM, Avan A, Shafiee M, Bahrami A, Tayefi M et al (2018) Hypertriglyceridemia is associated with white blood cell count and red cell distribution width: a gender stratified analysis in a population-based study. Acta MedIran 56(10):645","journal-title":"Acta MedIran"},{"issue":"1","key":"26_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2009.02.002","volume":"206","author":"TW Hein","year":"2009","unstructured":"Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206(1):61\u201368","journal-title":"Atherosclerosis"},{"issue":"19","key":"26_CR51","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0195-668X(03)00467-6","volume":"24","author":"KB Holven","year":"2003","unstructured":"Holven KB, Myhre AM, Aukrust P, Hagve TA, Ose L, Nenseter MS (2003) Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo: dependency of xanthomas\/xanthelasms, smoking and gender. Eur Heart J 24(19):1756\u20131762","journal-title":"Eur Heart J"},{"issue":"1","key":"26_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.ATV.0000193619.67288.ed","volume":"26","author":"KB Holven","year":"2006","unstructured":"Holven KB, Dam\u00e5s JK, Yndestad A, W\u00e6hre T, Ueland T, Halvorsen B et al (2006) Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES. Arterioscler Thromb Vasc Biol 26(1):200\u2013205","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"26_CR53","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2014.01.022","volume":"233","author":"KB Holven","year":"2014","unstructured":"Holven KB, Narverud I, Lindvig HW, Halvorsen B, Langslet G, Nenseter MS et al (2014) Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment. Atherosclerosis 233(2):561\u2013567","journal-title":"Atherosclerosis"},{"issue":"4","key":"26_CR54","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diabetes.53.4.1068","volume":"53","author":"P Holvoet","year":"2004","unstructured":"Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J et al (2004) The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 53(4):1068\u20131073","journal-title":"Diabetes"},{"issue":"4","key":"26_CR55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jacl.2010.02.011","volume":"4","author":"A Hovland","year":"2010","unstructured":"Hovland A, Aagnes I, Brekke O-L, Flage JH, Lappeg\u00e5rd KT (2010) No evidence of impaired endothelial function or altered inflammatory state in patients with familial hypercholesterolemia treated with statins. J Clin Lipidol 4(4):288\u2013292","journal-title":"J Clin Lipidol"},{"issue":"1","key":"26_CR56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacl.2015.10.006","volume":"10","author":"H Hussein","year":"2016","unstructured":"Hussein H, Saheb S, Couturier M, Atassi M, Orsoni A, Carri\u00e9 A et al (2016) Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: partial correction by low-density lipoprotein apheresis. J Clin Lipidol 10(1):124\u2013133","journal-title":"J Clin Lipidol"},{"issue":"2","key":"26_CR57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0003319715579781","volume":"67","author":"A Icli","year":"2016","unstructured":"Icli A, Aksoy F, Nar G, Kaymaz H, Alpay MF, Nar R et al (2016) Increased mean platelet volume in familial hypercholesterolemia. Angiology 67(2):146\u2013150","journal-title":"Angiology"},{"issue":"3","key":"26_CR58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1590\/1678-4685-gmb-2016-0287","volume":"41","author":"M Idrees","year":"2018","unstructured":"Idrees M, Siddiq AR, Ajmal M, Akram M, Khalid RR, Hussain A et al (2018) Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene. Genet Mol Biol 41(3):570\u2013577","journal-title":"Genet Mol Biol"},{"issue":"11","key":"26_CR59","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0735-1097(17)34908-2","volume":"69","author":"KP Iosif","year":"2017","unstructured":"Iosif KP, Toutouzas K, Benetos G, Skoumas I, Kafouris P, Georgakopoulos A et al (2017) Increased subclinical systemic and vascular inflammation in familial combined hyperlipidemia compared to heterozygous hypercholesterolemia: insights from a positron emission tomography study. J Am College Cardiol 69(11):1519","journal-title":"J Am College Cardiol"},{"issue":"5","key":"26_CR60","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11883-012-0267-7","volume":"14","author":"H Iwata","year":"2012","unstructured":"Iwata H, Nagai R (2012) Novel immune signals and atherosclerosis. Curr Atheroscler Rep 14(5):484\u2013490","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"26_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00041433-200204000-00008","volume":"13","author":"AC Jansen","year":"2002","unstructured":"Jansen AC, van Wissen S, Defesche JC, Kastelein JJ (2002) Phenotypic variability in familial hypercholesterolaemia: an update. Curr Opin Lipidol 13(2):165\u2013171","journal-title":"Curr Opin Lipidol"},{"key":"26_CR62","doi-asserted-by":"crossref","unstructured":"Jehli\u010dka P, Sto\u017eick\u00fd F, Mayer O Jr, Varva\u0159ovsk\u00e1 J, Racek J, Trefil L et al (2009) Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. Physiol Res 58(2)","DOI":"10.33549\/physiolres.931418"},{"issue":"2","key":"26_CR63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2005.11.006","volume":"113","author":"N Johnston","year":"2006","unstructured":"Johnston N, Jernberg T, Lagerqvist B, Siegbahn A, Wallentin L (2006) Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease. Int J Cardiol 113(2):167\u2013173","journal-title":"Int J Cardiol"},{"issue":"10","key":"26_CR64","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamacardio.2018.2769","volume":"3","author":"AA Joshi","year":"2018","unstructured":"Joshi AA, Lerman JB, Dey AK, Sajja AP, Belur AD, Elnabawi YA et al (2018) Association between aortic vascular inflammation and coronary artery plaque characteristics in psoriasis. JAMA Cardiol 3(10):949\u2013956","journal-title":"JAMA Cardiol"},{"issue":"17","key":"26_CR65","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","volume":"22","author":"S Kamath","year":"2001","unstructured":"Kamath S, Blann A, Lip G (2001) Platelet activation: assessment and quantification. Eur Heart J 22(17):1561\u20131571","journal-title":"Eur Heart J"},{"issue":"15","key":"26_CR66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.lfs.2013.08.003","volume":"93","author":"MS Karbiner","year":"2013","unstructured":"Karbiner MS, Sierra L, Minahk C, Fonio MC, Bruno MP, Jerez S (2013) The role of oxidative stress in alterations of hematological parameters and inflammatory markers induced by early hypercholesterolemia. Life Sci 93(15):503\u2013508","journal-title":"Life Sci"},{"issue":"17","key":"26_CR67","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","volume":"108","author":"J Karvonen","year":"2003","unstructured":"Karvonen J, Paivansalo M, Kesaniemi YA, Horkko S (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108(17):2107\u20132112","journal-title":"Circulation"},{"issue":"21","key":"26_CR68","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1161\/01.CIR.0000147828.86593.85","volume":"110","author":"Y Kashiwakura","year":"2004","unstructured":"Kashiwakura Y, Watanabe M, Kusumi N, Sumiyoshi K, Nasu Y, Yamada H et al (2004) Dynamin-2 regulates oxidized low-density lipoprotein\u2013induced apoptosis of vascular smooth muscle cell. Circulation 110(21):3329\u20133334","journal-title":"Circulation"},{"issue":"1","key":"26_CR69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1567-5688(03)00007-2","volume":"4","author":"JJ Kastelein","year":"2003","unstructured":"Kastelein JJ, Wiegman A, de Groot E (2003) Surrogate markers of atherosclerosis: impact of statins. Atheroscler Suppl 4(1):31\u201336","journal-title":"Atheroscler Suppl"},{"issue":"1","key":"26_CR70","first-page":"8","volume":"1","author":"R Khemka","year":"2014","unstructured":"Khemka R, Kulkarni K (2014) Study of relationship between platelet volume indices and hyperlipidemia. Ann Pathol Lab Med 1(1):8\u201314","journal-title":"Ann Pathol Lab Med"},{"key":"26_CR71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCULATIONAHA.105.575241","volume":"113","author":"A Khera","year":"2005","unstructured":"Khera A, de Lemos JA, Peshock R, Lo SH, Stanek GH, Murphy SA et al (2005) Relationship between C-reactive protein and subclinical atherosclerosis. The Dallas heart study. Circulation 113:38\u201343","journal-title":"Circulation"},{"issue":"4","key":"26_CR72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9149(02)03268-X","volume":"91","author":"S Kinlay","year":"2003","unstructured":"Kinlay S, Selwyn AP (2003) Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol 91(4):9\u201313","journal-title":"Am J Cardiol"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1471-2458-6-262","volume":"6","author":"A Kramer","year":"2006","unstructured":"Kramer A, Jansen AC, van Aalst-Cohen ES, Tanck MW, Kastelein JJ, Zwinderman AH (2006) Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 years excess risk in individuals with familial hypercholesterolemia. BMC Public Health 6:262","journal-title":"BMC Public Health"},{"issue":"2","key":"26_CR74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.RES.73.2.335","volume":"73","author":"K Kugiyama","year":"1993","unstructured":"Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H et al (1993) Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res 73(2):335\u2013343","journal-title":"Circ Res"},{"issue":"3","key":"26_CR75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.dsx.2017.09.006","volume":"12","author":"R Kumari","year":"2018","unstructured":"Kumari R, Kumar S, Ahmad MK, Singh R, Pradhan A, Chandra S et al (2018) TNF-alpha\/IL-10 ratio: an independent predictor for coronary artery disease in north Indian population. Diabetes Metab Syndr 12(3):221\u2013225","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"26_CR76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2006.07.006","volume":"193","author":"SG Lakoski","year":"2007","unstructured":"Lakoski SG, Cushman M, Blumenthal RS, Kronmal R, Arnett D, D\u2019Agostino RB Jr et al (2007) Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis 193(2):401\u2013407","journal-title":"Atherosclerosis"},{"issue":"1","key":"26_CR77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.294.1.56","volume":"294","author":"IM Lee","year":"2005","unstructured":"Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE et al (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's health study: a randomized controlled trial. JAMA 294(1):56\u201365","journal-title":"JAMA"},{"issue":"1","key":"26_CR78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1034\/j.1600-065X.2002.18602.x","volume":"186","author":"K Ley","year":"2002","unstructured":"Ley K (2002) Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186(1):8\u201318","journal-title":"Immunol Rev"},{"issue":"6917","key":"26_CR79","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874","journal-title":"Nature"},{"issue":"1","key":"26_CR80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1160\/TH16-08-0593","volume":"117","author":"L Liberale","year":"2017","unstructured":"Liberale L, Dallegri F, Montecucco F, Carbone F (2017) Pathophysiological relevance of macrophage subsets in atherogenesis. Thromb Haemost 117(1):7\u201318","journal-title":"Thromb Haemost"},{"issue":"5","key":"26_CR81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00041433-200110000-00003","volume":"12","author":"MF Linton","year":"2001","unstructured":"Linton MF, Fazio S (2001) Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol 12(5):489\u2013495","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"26_CR82","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","volume":"85","author":"Z Mallat","year":"1999","unstructured":"Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85(8):e17\u2013e24","journal-title":"Circ Res"},{"issue":"1","key":"26_CR83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2007.12.014","volume":"200","author":"LR Martinez","year":"2008","unstructured":"Martinez LR, Miname MH, Bortolotto LA, Chacra AP, Rochitte CE, Sposito AC et al (2008) No correlation and low agreement of imaging and inflammatory atherosclerosis\u2019 markers in familial hypercholesterolemia. Atherosclerosis 200(1):83\u201388","journal-title":"Atherosclerosis"},{"issue":"6","key":"26_CR84","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOL.0000000000000553","volume":"29","author":"P Mata","year":"2018","unstructured":"Mata P, Alonso R, Perez de Isla L (2018) Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all? Curr Opin Lipidol 29(6):445\u2013452","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"26_CR85","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2018.01.012","volume":"28","author":"A Mattina","year":"2018","unstructured":"Mattina A, Rosenbaum D, Bittar R, Bonnefont-Rousselot D, Noto D, Averna M et al (2018) Lipoprotein-associated phospholipase A2 activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia. Nutr Metab Cardiovasc Dis 28(5):517\u2013523","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"26_CR86","unstructured":"Mawhin M-A (2017) Role of neutrophils and leukotrienes in atherosclerotic plaque destabilisation: implication of endotoxemia. Strasbourg"},{"issue":"2","key":"26_CR87","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0021-9150(01)00528-7","volume":"159","author":"MJ McNeely","year":"2001","unstructured":"McNeely MJ, Edwards KL, Marcovina SM, Brunzell JD, Motulsky AG, Austin MA (2001) Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study. Atherosclerosis 159(2):471\u2013481","journal-title":"Atherosclerosis"},{"issue":"5","key":"26_CR88","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","volume":"112","author":"C Meisinger","year":"2005","unstructured":"Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112(5):651\u2013657","journal-title":"Circulation"},{"issue":"15","key":"26_CR89","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","volume":"101","author":"C Monaco","year":"2004","unstructured":"Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B et al (2004) Canonical pathway of nuclear factor \u03baB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci 101(15):5634\u20135639","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"26_CR90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11883-017-0646-1","volume":"19","author":"F Montecucco","year":"2017","unstructured":"Montecucco F, Liberale L, Bonaventura A, Vecchie A, Dallegri F, Carbone F (2017) The role of inflammation in cardiovascular outcome. Curr Atheroscler Rep 19(3):11","journal-title":"Curr Atheroscler Rep"},{"issue":"8856","key":"26_CR91","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0140-6736(93)90815-X","volume":"341","author":"S Moorjani","year":"1993","unstructured":"Moorjani S, Torres A, Gagn C, Brun D, Lupien P, Roy M et al (1993) Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 341(8856):1303\u20131306","journal-title":"Lancet"},{"issue":"3","key":"26_CR92","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1096\/fj.08-118240","volume":"23","author":"S Mosig","year":"2009","unstructured":"Mosig S, Rennert K, Krause S, Kzhyshkowska J, Neun\u00fcbel K, Heller R et al (2009) Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 23(3):866\u2013874","journal-title":"FASEB J"},{"issue":"2","key":"26_CR93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3(2):175\u2013187","journal-title":"Curr Drug Metab"},{"issue":"1","key":"26_CR94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2010.10.002","volume":"214","author":"I Narverud","year":"2011","unstructured":"Narverud I, Ueland T, Nenseter MS, Retterst\u00f8l K, Telle-Hansen VH, Halvorsen B et al (2011a) Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor \u03b1 system and interleukin-10. Atherosclerosis 214(1):163\u2013168","journal-title":"Atherosclerosis"},{"issue":"1","key":"26_CR95","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2010.10.002","volume":"214","author":"I Narverud","year":"2011","unstructured":"Narverud I, Ueland T, Nenseter MS, Retterstol K, Telle-Hansen VH, Halvorsen B et al (2011b) Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor alpha system and interleukin-10. Atherosclerosis 214(1):163\u2013168","journal-title":"Atherosclerosis"},{"issue":"1","key":"26_CR96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.2012.02584.x","volume":"273","author":"I Narverud","year":"2013","unstructured":"Narverud I, Halvorsen B, Nenseter M, Retterst\u00f8l K, Yndestad A, Dahl T et al (2013a) Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia. J Intern Med 273(1):69\u201378","journal-title":"J Intern Med"},{"issue":"2","key":"26_CR97","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.thromres.2012.11.008","volume":"131","author":"I Narverud","year":"2013","unstructured":"Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG et al (2013b) Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH. Thromb Res 131(2):178\u2013182","journal-title":"Thromb Res"},{"issue":"2","key":"26_CR98","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2014.05.917","volume":"235","author":"I Narverud","year":"2014","unstructured":"Narverud I, Retterstol K, Iversen PO, Halvorsen B, Ueland T, Ulven SM et al (2014) Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review. Atherosclerosis 235(2):299\u2013309","journal-title":"Atherosclerosis"},{"issue":"6","key":"26_CR99","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","volume":"45","author":"M Navab","year":"2004","unstructured":"Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC et al (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res 45(6):993\u20131007","journal-title":"J Lipid Res"},{"issue":"4","key":"26_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122139","volume":"10","author":"MH Nielsen","year":"2015","unstructured":"Nielsen MH, Irvine H, Vedel S, Raungaard B, Beck-Nielsen H, Handberg A (2015) Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One 10(4):e0121516","journal-title":"PLoS One"},{"issue":"4","key":"26_CR101","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2796.2003.01128.x","volume":"253","author":"G Nordin Fredrikson","year":"2003","unstructured":"Nordin Fredrikson G, Hedblad B, Berglund G, Nilsson J (2003) Plasma oxidized LDL: a predictor for acute myocardial infarction? J Intern Med 253(4):425\u2013429","journal-title":"J Intern Med"},{"issue":"1","key":"26_CR102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","volume":"54","author":"RR Packard","year":"2008","unstructured":"Packard RR, Libby P (2008) Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54(1):24\u201338","journal-title":"Clin Chem"},{"issue":"5\u20136","key":"26_CR103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/095371002220148332","volume":"13","author":"Y Park","year":"2002","unstructured":"Park Y, Schoene N, Harris W (2002) Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 13(5\u20136):301\u2013306","journal-title":"Platelets"},{"issue":"18","key":"26_CR104","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18):2165\u20132168","journal-title":"Circulation"},{"issue":"21","key":"26_CR105","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V Pasceri","year":"2001","unstructured":"Pasceri V, Chang J, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein\u2013mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103(21):2531\u20132534","journal-title":"Circulation"},{"issue":"1","key":"26_CR106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.ATV.19.1.54","volume":"19","author":"G Pasterkamp","year":"1999","unstructured":"Pasterkamp G, Schoneveld AH, van der Wal AC, Hijnen DJ, van Wolveren WJ, Plomp S et al (1999) Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscler Thromb Vasc Biol 19(1):54\u201358","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"26_CR107","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/2047487317717346","volume":"24","author":"I Pecin","year":"2017","unstructured":"Pecin I, Hartgers ML, Hovingh GK, Dent R, Reiner Z (2017) Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: the role of PCSK9 inhibitors. Eur J Prev Cardiol 24(13):1383\u20131401","journal-title":"Eur J Prev Cardiol"},{"key":"26_CR108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2019.05.003","volume":"286","author":"L Perez de Isla","year":"2019","unstructured":"Perez de Isla L, Ray KK, Watts GF, Santos RD, Alonso R, Muniz-Grijalvo O et al (2019) Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis 286:40\u201345","journal-title":"Atherosclerosis"},{"issue":"22","key":"26_CR109","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jacc.2017.04.010","volume":"69","author":"NVK Pothineni","year":"2017","unstructured":"Pothineni NVK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI, Mehta JL (2017) LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation. J Am Coll Cardiol 69(22):2759\u20132768","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"26_CR110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12944-017-0470-1","volume":"16","author":"T Rahman","year":"2017","unstructured":"Rahman T, Hamzan NS, Mokhsin A, Rahmat R, Ibrahim ZO, Razali R et al (2017) Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study. Lipids Health Dis 16(1):81","journal-title":"Lipids Health Dis"},{"issue":"2","key":"26_CR111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2362.2009.02218.x","volume":"40","author":"J Real","year":"2010","unstructured":"Real J, Mart\u00ednez-Herv\u00e1s S, Garc\u00eda-Garc\u00eda A, Civera M, Pallard\u00f3 F, Ascaso J et al (2010a) Circulating mononuclear cells nuclear factor-kappa B activity, plasma xanthine oxidase, and low grade inflammatory markers in adult patients with familial hypercholesterolaemia. Eur J Clin Investig 40(2):89\u201394","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"26_CR112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2362.2009.02218.x","volume":"40","author":"JT Real","year":"2010","unstructured":"Real JT, Martinez-Hervas S, Garcia-Garcia AB, Civera M, Pallardo FV, Ascaso JF et al (2010b) Circulating mononuclear cells nuclear factor-kappa B activity, plasma xanthine oxidase, and low grade inflammatory markers in adult patients with familial hypercholesterolaemia. Eur J Clin Investig 40(2):89\u201394","journal-title":"Eur J Clin Investig"},{"issue":"10","key":"26_CR113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrcardio.2015.92","volume":"12","author":"Z Reiner","year":"2015","unstructured":"Reiner Z (2015) Management of patients with familial hypercholesterolaemia. Nat Rev Cardiol 12(10):565\u2013575","journal-title":"Nat Rev Cardiol"},{"key":"26_CR114","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2018.01.001","volume":"270","author":"Z Reiner","year":"2018","unstructured":"Reiner Z (2018) PCSK9 inhibitors in clinical practice: expectations and reality. Atherosclerosis 270:187\u2013188","journal-title":"Atherosclerosis"},{"issue":"14","key":"26_CR115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336(14):973\u2013979","journal-title":"N Engl J Med"},{"issue":"12","key":"26_CR116","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119\u20131131","journal-title":"N Engl J Med"},{"issue":"38","key":"26_CR117","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","volume":"39","author":"PM Ridker","year":"2018","unstructured":"Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F et al (2018) Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Eur Heart J 39(38):3499\u20133507","journal-title":"Eur Heart J"},{"issue":"1","key":"26_CR118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1749-6632.2001.tb03939.x","volume":"947","author":"L Robbie","year":"2001","unstructured":"Robbie L, Libby P (2001) Inflammation and atherothrombosis. Ann N Y Acad Sci 947(1):167\u2013180","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"26_CR119","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","volume":"47","author":"J Rodenburg","year":"2006","unstructured":"Rodenburg J, Vissers MN, Wiegman A, Miller ER, Ridker PM, Witztum JL et al (2006) Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J Am Coll Cardiol 47(9):1803\u20131810","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"26_CR120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2014an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"1","key":"26_CR121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jacl.2010.11.001","volume":"5","author":"SK Ryu","year":"2011","unstructured":"Ryu SK, Hutten BA, Vissers MN, Wiegman A, Kastelein JJ, Tsimikas S (2011) Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J Clin Lipidol 5(1):50\u201356","journal-title":"J Clin Lipidol"},{"issue":"10","key":"26_CR122","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","volume":"4","author":"RD Santos","year":"2016","unstructured":"Santos RD, Gidding SS, Hegele RA, Cuchel MA, Barter PJ, Watts GF et al (2016) Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the international atherosclerosis society severe familial hypercholesterolemia panel. Lancet Diabetes Endocrinol 4(10):850\u2013861","journal-title":"Lancet Diabetes Endocrinol"},{"key":"26_CR123","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.6061\/clinics\/2018\/e203","volume":"73","author":"JCD Santos","year":"2018","unstructured":"Santos JCD, Cruz MS, Bortolin RH, Oliveira KM, Araujo JNG, Duarte VHR et al (2018) Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions. Clinics (Sao Paulo, Brazil) 73:e203","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"10","key":"26_CR124","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/ATVBAHA.107.147280","volume":"27","author":"VG Saougos","year":"2007","unstructured":"Saougos VG, Tambaki AP, Kalogirou M, Kostapanos M, Gazi IF, Wolfert RL et al (2007) Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2. Arterioscler Thromb Vasc Biol 27(10):2236\u20132243","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"26_CR125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0735-1097(02)02718-3","volume":"41","author":"AG Semb","year":"2003","unstructured":"Semb AG, van Wissen S, Ueland T, Smilde T, Waehre T, Tripp MD et al (2003) Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. J Am Coll Cardiol 41(2):275\u2013279","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"26_CR126","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heartjnl-2015-308845","volume":"102","author":"M Sharifi","year":"2016","unstructured":"Sharifi M, Rakhit RD, Humphries SE, Nair D (2016) Cardiovascular risk stratification in familial hypercholesterolaemia. Heart 102(13):1003\u20131008","journal-title":"Heart"},{"issue":"17","key":"26_CR127","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","volume":"110","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Wu R, Dearing LD, Matsuura E (2004) Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110(17):2552\u20132558","journal-title":"Circulation"},{"issue":"2","key":"26_CR128","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1536\/ihj.15-346","volume":"57","author":"T Soeki","year":"2016","unstructured":"Soeki T, Sata M (2016) Inflammatory biomarkers and atherosclerosis. Int Heart J 57(2):134\u2013139","journal-title":"Int Heart J"},{"issue":"4","key":"26_CR129","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar AK, Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Rev Cardiol 4(4):214","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"26_CR130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","volume":"23","author":"DM Stafforini","year":"2009","unstructured":"Stafforini DM (2009) Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A 2). Cardiovasc Drugs Ther 23(1):73\u201383","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"26_CR131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2012.06.010","volume":"224","author":"G St\u00fcbiger","year":"2012","unstructured":"St\u00fcbiger G, Aldover-Macasaet E, Bicker W, Sobal G, Willfort-Ehringer A, Pock K et al (2012) Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS\/MS. Atherosclerosis 224(1):177\u2013186","journal-title":"Atherosclerosis"},{"issue":"1","key":"26_CR132","first-page":"99","volume":"141","author":"N Sugiyama","year":"1992","unstructured":"Sugiyama N, Marcovina S, Gown AM, Seftel H, Joffe B, Chait A (1992) Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia. Am J Pathol 141(1):99\u2013106","journal-title":"Am J Pathol"},{"issue":"12","key":"26_CR133","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1002\/jcb.26084","volume":"118","author":"SA Tabatabaeizadeh","year":"2017","unstructured":"Tabatabaeizadeh SA, Avan A, Bahrami A, Khodashenas E, Esmaeili H, Ferns GA et al (2017) High dose supplementation of vitamin D affects measures of systemic inflammation: reductions in high sensitivity C-reactive protein level and neutrophil to lymphocyte ratio (NLR) distribution. J Cell Biochem 118(12):4317\u20134322","journal-title":"J Cell Biochem"},{"issue":"1","key":"26_CR134","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"F Tacke","year":"2007","unstructured":"Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J et al (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117(1):185\u2013194","journal-title":"J Clin Invest"},{"issue":"1","key":"26_CR135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS (2001) NF-\u03baB: a key role in inflammatory diseases. J Clin Invest 107(1):7\u201311","journal-title":"J Clin Invest"},{"key":"26_CR136","doi-asserted-by":"crossref","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP et al (2019) Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med","DOI":"10.1056\/NEJMoa1912388"},{"key":"26_CR137","doi-asserted-by":"crossref","first-page":"762759","DOI":"10.1155\/2013\/762759","volume":"2013","author":"IO Tekin","year":"2013","unstructured":"Tekin IO, Orem A, Shiri-Sverdlov R (2013) Oxidized LDL in inflammation: from bench to bedside. Mediat Inflamm 2013:762759","journal-title":"Mediat Inflamm"},{"issue":"9","key":"26_CR138","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjcard.2018.01.020","volume":"121","author":"M Tibuakuu","year":"2018","unstructured":"Tibuakuu M, Kianoush S, DeFilippis AP, McEvoy JW, Zhao D, Guallar E et al (2018) Usefulness of lipoprotein-associated phospholipase A2 activity and C-reactive protein in identifying high-risk smokers for atherosclerotic cardiovascular disease (from the atherosclerosis risk in communities study). Am J Cardiol 121(9):1056\u20131064","journal-title":"Am J Cardiol"},{"issue":"22","key":"26_CR139","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","volume":"37","author":"D Tousoulis","year":"2016","unstructured":"Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC (2016) Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J 37(22):1723\u20131732","journal-title":"Eur Heart J"},{"issue":"1","key":"26_CR140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2017.10.019","volume":"12","author":"K Toutouzas","year":"2018","unstructured":"Toutouzas K, Skoumas J, Koutagiar I, Benetos G, Pianou N, Georgakopoulos A et al (2018) Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia. J Clin Lipidol 12(1):33\u201343","journal-title":"J Clin Lipidol"},{"issue":"3","key":"26_CR141","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","volume":"41","author":"S Tsimikas","year":"2003","unstructured":"Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E et al (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41(3):360\u2013370","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"26_CR142","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","volume":"27","author":"S Tsimikas","year":"2007","unstructured":"Tsimikas S, Tsironis LD, Tselepis AD (2007) New insights into the role of lipoprotein (a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 27(10):2094\u20132099","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"26_CR143","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","volume":"60","author":"S Tsimikas","year":"2012","unstructured":"Tsimikas S, Willeit P, Willeit J, Santer P, Mayr M, Xu Q et al (2012) Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events. J Am Coll Cardiol 60(21):2218\u20132229","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"26_CR144","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2362.2006.01613.x","volume":"36","author":"T Ueland","year":"2006","unstructured":"Ueland T, Vissers M, Wiegman A, Rodenburg J, Hutten B, Gullestad L et al (2006) Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Investig 36(3):147\u2013152","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"26_CR145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P088997","volume":"60","author":"EH van den Berg","year":"2019","unstructured":"van den Berg EH, Gruppen EG, James RW, Bakker SJ, Dullaart RP (2019) Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. J Lipid Res 60(1):168\u2013175","journal-title":"J Lipid Res"},{"issue":"6","key":"26_CR146","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/CS20020293","volume":"104","author":"PL van Haelst","year":"2003","unstructured":"van Haelst PL, van Doormaal JJ, Asselbergs FW, Veeger NJ, Henneman MM, Tervaert JWC et al (2003) Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clin Sci 104(6):627\u2013632","journal-title":"Clin Sci"},{"issue":"3","key":"26_CR147","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1194\/jlr.M400052-JLR200","volume":"46","author":"TM van Himbergen","year":"2005","unstructured":"van Himbergen TM, Roest M, de Graaf J, Jansen EH, Hattori H, Kastelein JJ et al (2005) Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 46(3):445\u2013451","journal-title":"J Lipid Res"},{"issue":"1","key":"26_CR148","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.LAB.0000048633.76607.E0","volume":"83","author":"L Van Tits","year":"2003","unstructured":"Van Tits L, De Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P et al (2003) Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Investig 83(1):13\u201321","journal-title":"Lab Investig"},{"issue":"10","key":"26_CR149","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1742-1241.2009.02070.x","volume":"63","author":"L Vizioli","year":"2009","unstructured":"Vizioli L, Muscari S, Muscari A (2009) The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 63(10):1509\u20131515","journal-title":"Int J Clin Pract"},{"key":"26_CR150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2423(08)60182-1","volume":"27","author":"H Wachter","year":"1989","unstructured":"Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER (1989) Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 27:81\u2013141","journal-title":"Adv Clin Chem"},{"issue":"5","key":"26_CR151","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2796.2004.01402.x","volume":"256","author":"K Wallenfeldt","year":"2004","unstructured":"Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J (2004) Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med 256(5):413\u2013420","journal-title":"J Intern Med"},{"issue":"6","key":"26_CR152","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003407","volume":"5","author":"L Wallentin","year":"2016","unstructured":"Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB et al (2016) Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease. J Am Heart Assoc 5(6):e003407","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"26_CR153","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjcard.2008.04.013","volume":"101","author":"HS Weintraub","year":"2008","unstructured":"Weintraub HS (2008) Identifying the vulnerable patient with rupture-prone plaque. Am J Cardiol 101(12):S3\u2013S10","journal-title":"Am J Cardiol"},{"issue":"19","key":"26_CR154","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1046\/j.1432-1327.2000.01682.x","volume":"267","author":"ES Wintergerst","year":"2000","unstructured":"Wintergerst ES, Jelk J, Rahner C, Asmis R (2000) Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. Eur J Biochem 267(19):6050\u20136059","journal-title":"Eur J Biochem"},{"issue":"16","key":"26_CR155","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","volume":"70","author":"S Xu","year":"2013","unstructured":"Xu S, Ogura S, Chen J, Little PJ, Moss J, Liu P (2013) LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 70(16):2859\u20132872","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"26_CR156","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000191655.87296.ab","volume":"26","author":"EH Yang","year":"2006","unstructured":"Yang EH, McConnell JP, Lennon RJ, Barsness GW, Pumper G, Hartman SJ et al (2006) Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 26(1):106\u2013111","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"26_CR157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000374105","volume":"131","author":"M Yuan","year":"2015","unstructured":"Yuan M, Fu H, Ren L, Wang H, Guo W (2015) Soluble CD40 ligand promotes macrophage foam cell formation in the etiology of atherosclerosis. Cardiology 131(1):1\u201312","journal-title":"Cardiology"},{"issue":"2","key":"26_CR158","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1472-8206.2011.01023.x","volume":"26","author":"F Zannad","year":"2012","unstructured":"Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA et al (2012) Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol 26(2):163\u2013174","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"26_CR159","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/cvr\/cvp391","volume":"86","author":"A Zernecke","year":"2009","unstructured":"Zernecke A, Weber C (2009) Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 86(2):192\u2013201","journal-title":"Cardiovasc Res"},{"issue":"8","key":"26_CR160","first-page":"11922","volume":"8","author":"J Zhang","year":"2015","unstructured":"Zhang J, Wang D, He S (2015) Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances. Int J Clin Exp Med 8(8):11922\u201311929","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"26_CR161","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0167-5699(96)10029-3","volume":"17","author":"H Ziegler-Heitbrock","year":"1996","unstructured":"Ziegler-Heitbrock H (1996) Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 17(9):424\u2013428","journal-title":"Immunol Today"}],"container-title":["Reviews of Physiology, Biochemistry and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/112_2020_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:38:32Z","timestamp":1667479112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/112_2020_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030614942","9783030614959"],"references-count":161,"URL":"https:\/\/doi.org\/10.1007\/112_2020_26","relation":{},"ISSN":["0303-4240","1617-5786"],"issn-type":[{"type":"print","value":"0303-4240"},{"type":"electronic","value":"1617-5786"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"21 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}